The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Phosphodiesterases in the CNS: targets for drug development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Family of cAMP-Binding Proteins That Directly Activate Rap1
Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D. E., & Graybiel, A. M. (1998) · Science · doi:10.1126/science.282.5397.2275 · Cited by 1,362
Nibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051
Lugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury
Pearse, D. D., Pereira, F. C., Marcillo, A. E., Bates, M. L., Berrocal, Y. A., Filbin, M. T., & Bunge, M. B. (2004) · Nature Medicine · doi:10.1038/nm1056 · Cited by 727
Studies on the Mechanism of Hormone Action
Sutherland, E. W. (1972) · Science · doi:10.1126/science.177.4047.401 · Cited by 687
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
dunce, a mutant of Drosophila deficient in learning.
Dudai, Y., Jan, Y. N., Byers, D., Quinn, W. G., & Benzer, S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.5.1684 · Cited by 618
AKAPs: from structure to function
Colledge, M., & Scott, J. D. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01558-5 · Cited by 611
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
A general pattern for substrate recognition by P‐glycoprotein
Seelig, A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510252.x · Cited by 527
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980402t · Cited by 519
Epac: a new cAMP target and new avenues in cAMP research
Bos, J. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1197 · Cited by 489
Nakagawa, S., Kim, J.-E., Lee, R., Malberg, J. E., Chen, J., Steffen, C., Zhang, Y.-J., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03673.2002 · Cited by 485
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
Conti, M., Richter, W., Mehats, C., Livera, G., Park, J.-Y., & Jin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200029200 · Cited by 481
Multiple cyclic nucleotide phosphodiesterases.
Beavo, J. A., Conti, M., & Heaslip, R. J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09714-7 · Cited by 472
Gong, B., Vitolo, O. V., Trinchese, F., Liu, S., Shelanski, M., & Arancio, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22831 · Cited by 442
Tailoring cAMP-signalling responses through isoform multiplicity
Houslay, M. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01050-5 · Cited by 439
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Card, G. L., England, B. P., Suzuki, Y., Fong, D., Powell, B., Lee, B., Luu, C., Tabrizizad, M., Gillette, S., Ibrahim, P. N., et al. (2004) · Structure · doi:10.1016/j.str.2004.10.004 · Cited by 432
Barad, M., Bourtchouladze, R., Winder, D. G., Golan, H., & Kandel, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15020 · Cited by 431
Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A
Soderling, S. H., Bayuga, S. J., & Beavo, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7071 · Cited by 374
Immunohistochemical localization of PDE10A in the rat brain
Seeger, T. F., Bartlett, B., Coskran, T. M., Culp, J. S., James, L. C., Krull, D. L., Lanfear, J., Ryan, A. M., Schmidt, C. J., Strick, C. A., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02754-9 · Cited by 334
Self-citationBoess, F. G., Hendrix, M., van der Staay, F.-J., Erb, C., Schreiber, R., van Staveren, W., de Vente, J., Prickaerts, J., Blokland, A., & Koenig, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.040 · Cited by 330
Cyclic Nucleotide-Gated Ion Channels: An Extended Family With Diverse Functions
Finn, J. T., Grunwald, M. E., & Yau, K.-W. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.002143 · Cited by 326
The Role of the Cerebellum in Cognition and Behavior: A Selective Review
Rapoport, M., van Reekum, R., & Mayberg, H. (2000) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.12.2.193 · Cited by 313
A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3
Straub, R. E., Lehner, T., Luo, Y., Loth, J. E., Shao, W., Sharpe, L., Alexander, J. R., Das, K., Simon, R., Fieve, R. R., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-291 · Cited by 312
Juilfs, D. M., Fülle, H.-J., Zhao, A. Z., Houslay, M. D., Garbers, D. L., & Beavo, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3388 · Cited by 312
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
O'Donnell, J. M., & Zhang, H.-T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.003 · Cited by 307
Phosphodiesterase 5 inhibitors: current status and potential applications
Rotella, D. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd893 · Cited by 306
Computational approaches to the prediction of the blood–brain distribution
Norinder, U., & Haeberlein, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00005-4 · Cited by 305
Barnes, P. J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1524 · Cited by 280
Siuciak, J. A., Chapin, D. S., Harms, J. F., Lebel, L. A., McCarthy, S. A., Chambers, L., Shrikhande, A., Wong, S., Menniti, F. S., & Schmidt, C. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.013 · Cited by 278
Self-citationRobichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15506 · Cited by 267
Robichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215506 · Cited by 259
Jeon, Y. H., Heo, Y. S., Kim, C. M., Hyun, Y. L., Lee, T. G., Ro, S., & Cho, J. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4533-5 · Cited by 232
Siuciak, J. A., McCarthy, S. A., Chapin, D. S., Fujiwara, R. A., James, L. C., Williams, R. D., Stock, J. L., McNeish, J. D., Strick, C. A., Menniti, F. S., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.012 · Cited by 231
Self-citationPrickaerts, J., van Staveren, W. C. G., Şik, A., Markerink-van Ittersum, M., Niewöhner, U., van der Staay, F. J., Blokland, A., & de Vente, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00199-9 · Cited by 231
Cherry, J. A., & Davis, R. L. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990503)407:2<287::aid-cne9>3.0.co;2-r · Cited by 215
Isolation and characterization of PDE10A, a novel human 3′, 5′-cyclic nucleotide phosphodiesterase
Loughney, K., Snyder, P. B., Uher, L., Rosman, G. J., Ferguson, K., & Florio, V. A. (1999) · Gene · doi:10.1016/s0378-1119(99)00171-7 · Cited by 208
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase
Xie, Z., Adamowicz, W. O., Eldred, W. D., Jakowski, A. B., Kleiman, R. J., Morton, D. G., Stephenson, D. T., Strick, C. A., Williams, R. D., & Menniti, F. S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.042 · Cited by 198
Self-citationUpdate on the therapeutic potential of PDE4 inhibitors
Montana, J. G., & Dyke, H. J. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.1.1 · Cited by 196
Gao, Y., Nikulina, E., Mellado, W., & Filbin, M. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11770.2003 · Cited by 191
Fujishige, K., Kotera, J., & Omori, K. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00963.x · Cited by 188
Results of a Phase II Study of the Antidepressant Effect of Rolipram
Zeller, E., Stief, H., Pflug, B., & Sastre-y-Hernández, M. (1984) · Pharmacopsychiatry · doi:10.1055/s-2007-1017435 · Cited by 179
A cGMP-signaling pathway in a subset of olfactory sensory neurons
Meyer, M. R., Angele, A., Kremmer, E., Kaupp, U. B., & Müller, F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10595 · Cited by 174
Phosphodiesterase type 5 inhibition improves early memory consolidation of object information
Prickaerts, J., Şık, A., van Staveren, W. C. G., Koopmans, G. C., Steinbusch, H. W. M., van der Staay, F. J., de Vente, J., & Blokland, A. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.022 · Cited by 162
Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line
Wunder, F., Tersteegen, A., Rebmann, A., Erb, C., Fahrig, T., & Hendrix, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017608 · Cited by 149
Pérez-Torres, S., Cortés, R., Tolnay, M., Probst, A., Palacios, J. M., & Mengod, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00042-6 · Cited by 137
Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes
Baillie, G. S., & Houslay, M. D. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.01.003 · Cited by 133
Phosphodiesterase Inhibitors for Cognitive Enhancement
Rose, G., Hopper, A. T., Vivo, M. D., & Tehim, A. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774370799 · Cited by 123
Detera‐Wadleigh, S. D., Badner, J. A., Goldin, L. R., Berrettini, W. H., Sanders, A. R., Rollins, D. Y., Turner, G., Moses, T. Y., Haerian, H., Muniec, D., et al. (1996) · PubMed Central · Cited by 121
Schultheiss, D., Müller, S., Nager, W., Stief, C. G., Schlote, N., Udo Jonas, A., Asvestis, C., Johannes, S., & Münte, T. (2001) · World Journal of Urology · doi:10.1007/pl00007092 · Cited by 119
Kotera, J., Fujishige, K., & Omori, K. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800512 · Cited by 117
Monti, B., Berteotti, C., & Contestabile, A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300813 · Cited by 110
The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis
Snyder, P. B., Esselstyn, J. M., Loughney, K., Wolda, S. L., & Florio, V. A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400362-jlr200 · Cited by 110
Expression of cGMP-Specific Phosphodiesterase 9A mRNA in the Rat Brain
Andreeva, S. G., Dikkes, P., Epstein, P. M., & Rosenberg, P. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-22-09068.2001 · Cited by 107
Phosphodiesterase inhibitors: A novel mechanism for receptor-independent antipsychotic medications
Maxwell, C. R., Kanes, S., Abel, T. G., & Siegel, S. J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.038 · Cited by 107
Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3)
Shakur, Y., Takeda, K., Kenan, Y., Yu, Z., Rena, G., Brandt, D., Houslay, M. D., Degerman, E., Ferrans, V. J., & Manganiello, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001734200 · Cited by 103
Miró, X., Pérez-Torres, S., Palacios, J. M., Puigdomènech, P., & Mengod, G. (2001) · Synapse · doi:10.1002/syn.1043 · Cited by 100
Tissue expression, distribution, and regulation of PDE5
Lin, C.-S. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901207 · Cited by 98
Devan, B. D., SIERRAMERCADOJR, D., JIMENEZ, M., Bowker, J. L., Duffy, K. B., Spangler, E. L., & INGRAM, D. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.019 · Cited by 98
Repaske, D. R., Corbin, J. G., Conti, M., & Goy, M. F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90364-l · Cited by 96
Gardner, C., Robas, N. M., Cawkill, D., & Fidock, M. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2743 · Cited by 95
Suvarna, N. U., & O’Donnell, J. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.249 · Cited by 91
Kotera, J., Yanaka, N., Fujishige, K., Imai, Y., Akatsuka, H., Ishizuka, T., Kawashima, K., & Omori, K. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00434.x · Cited by 89
In Silico Prediction Models for Blood-Brain Barrier Permeation
Ecker, G. F., & Noe, C. R. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365071 · Cited by 86
Wang, H., Liu, Y., Chen, Y., Robinson, H. H., & Ke, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504398200 · Cited by 85
Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain
Reyes-Irisarri, E., Pérez-Torres, S., & Mengod, G. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.050 · Cited by 84
Inhibition of cGMP Breakdown Promotes the Induction of Cerebellar Long-Term Depression
Hartell, N. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-09-02881.1996 · Cited by 77
Guipponi, M., Scott, H. S., Kudoh, J., Kawasaki, K., Shibuya, K., Shintani, A., Asakawa, S., Chen, H., Lalioti, M. D., Rossier, C., et al. (1998) · Human Genetics · doi:10.1007/s004390050838 · Cited by 68
Sasaki, T., Kotera, J., & Omori, K. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610211 · Cited by 67
Padma-Nathan, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00828-2 · Cited by 61
Two Genes Link Two Distinct Psychoses
Sawa, A., & Snyder, S. H. (2005) · Science · doi:10.1126/science.1121114 · Cited by 51
Ahmed, T., & Frey, J. U. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00838-2 · Cited by 47
O'Connor, V. M., Génin, A., Davis, S., Karishma, K. K., Doyère, V., Zeeuw, C. I. D., Sanger, G. J., Hunt, S. P., Richter‐Levin, G., Mallet, J. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312500200 · Cited by 45
Reinhardt, R., & Bondy, C. A. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00520-x · Cited by 44
A new chemical tool for exploring the physiological function of the PDE2 isozyme
Chambers, R. J., Abrams, K., Garceau, N. Y., Kamath, A. V., Manley, C. M., Lilley, S. C., Otte, D. A. L., Scott, D. O., Sheils, A. L., Tess, D. A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.005 · Cited by 36
Houslay, M. D. (1995) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(94)00012-r · Cited by 33
Disposition of CP-671, 305, a selective phosphodiesterase 4 inhibitor in preclinical species
Kalgutkar, A. S. S., Choo, E. F., Taylor, T. J., & Marfat, A. (2004) · Xenobiotica · doi:10.1080/00498250400005682 · Cited by 20
Cited by
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409
Kaar, S. J., Natesan, S., McCutcheon, R., & Howes, O. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107704 · Cited by 383
Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
KESHAVAN, M., TANDON, R., BOUTROS, N., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.020 · Cited by 347
Neurophysiological biomarkers for drug development in schizophrenia
Javitt, D. C., Spencer, K. M., Thaker, G. K., Winterer, G., & Hajós, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2463 · Cited by 342
Metadata
- Authors
- Menniti, F. S., Faraci, W. S., & Schmidt, C. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-08
- Volume
- 5
- Issue
- 8
- Pages
- 660-670
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2048099169
- Cited by
- 391
- References
- 81
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.